AI assistant
Sending…
Akero Therapeutics, Inc. — Director's Dealing 2021
Apr 26, 2021
31200_dirs_2021-04-26_eb0b7352-1f48-4a16-8580-b35e91e20e31.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Akero Therapeutics, Inc. (AKRO)
CIK: 0001744659
Period of Report: 2021-04-22
Reporting Person: Xu Yuan (Director)
More from Akero Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2025
Dec 19
Delisting Announcement
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9